Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Vizzutti

Showing results (51-60 of 75) with videos related to

Pageof 8
Sort By:
Laboratory Investigation; a Journal of Technical Methods and Pathology|November 11, 2009
Curcumin limits the fibrogenic evolution of experimental steatohepatitisFrancesco Vizzutti, Angela Provenzano, Sara Galastri, et al.
Hepatology (Baltimore, Md.)|December 1, 2005
Upregulation of proinflammatory and proangiogenic cytokines by leptin in human hepatic stellate cellsSara Aleffi, Ilaria Petrai, Cristiana Bertolani, et al.
Hepatology (Baltimore, Md.)|April 28, 2007
Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosisFrancesco Vizzutti, Umberto Arena, Roberto G Romanelli, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 3, 2019
Transjugular Intrahepatic Portosystemic Shunt does not affect the efficacy and safety of direct-acting antivirals in patients with advanced cirrhosis: A real-life, case-control studyStefano Gitto, Francesco Vizzutti, Filippo Schepis, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 28, 2021
Portosystemic shunt is an effective treatment for complications of portal hypertension in hepatic myeloid metaplasia and improves nutritional statusSilvia Aspite, Filippo Schepis, Davide Roccarina, et al.
Blood|March 24, 2010
Safety and efficacy of rituximab in patients with hepatitis C virus-related mixed cryoglobulinemia and severe liver diseaseAntonio Petrarca, Luigi Rigacci, Patrizio Caini, et al.
Journal of Hepatology|November 28, 2006
Prevention of severe toxic liver injury and oxidative stress in MCP-1-deficient miceElena Zamara, Sara Galastri, Sara Aleffi, et al.
Clinical Science (London, England : 1979)|May 2, 2012
Lack of CC chemokine ligand 2 differentially affects inflammation and fibrosis according to the genetic background in a murine model of steatohepatitisSara Galastri, Elena Zamara, Stefano Milani, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|September 10, 2005
Thrombopoietin stimulates migration and activates multiple signaling pathways in hepatoblastoma cellsRoberto G Romanelli, Ilaria Petrai, Gaia Robino, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 26, 2016
Consensus conference on TIPS management: Techniques, indications, contraindicationsStefano Fagiuoli, Raffaele Bruno, Wilma Debernardi Venon, et al.
Pageof 8

Showing results (51-60 of 75) with videos related to

Sort By:
Pageof 8
Laboratory Investigation; a Journal of Technical Methods and Pathology|November 11, 2009
Curcumin limits the fibrogenic evolution of experimental steatohepatitisFrancesco Vizzutti, Angela Provenzano, Sara Galastri, et al.
Hepatology (Baltimore, Md.)|December 1, 2005
Upregulation of proinflammatory and proangiogenic cytokines by leptin in human hepatic stellate cellsSara Aleffi, Ilaria Petrai, Cristiana Bertolani, et al.
Hepatology (Baltimore, Md.)|April 28, 2007
Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosisFrancesco Vizzutti, Umberto Arena, Roberto G Romanelli, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 3, 2019
Transjugular Intrahepatic Portosystemic Shunt does not affect the efficacy and safety of direct-acting antivirals in patients with advanced cirrhosis: A real-life, case-control studyStefano Gitto, Francesco Vizzutti, Filippo Schepis, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 28, 2021
Portosystemic shunt is an effective treatment for complications of portal hypertension in hepatic myeloid metaplasia and improves nutritional statusSilvia Aspite, Filippo Schepis, Davide Roccarina, et al.
Blood|March 24, 2010
Safety and efficacy of rituximab in patients with hepatitis C virus-related mixed cryoglobulinemia and severe liver diseaseAntonio Petrarca, Luigi Rigacci, Patrizio Caini, et al.
Journal of Hepatology|November 28, 2006
Prevention of severe toxic liver injury and oxidative stress in MCP-1-deficient miceElena Zamara, Sara Galastri, Sara Aleffi, et al.
Clinical Science (London, England : 1979)|May 2, 2012
Lack of CC chemokine ligand 2 differentially affects inflammation and fibrosis according to the genetic background in a murine model of steatohepatitisSara Galastri, Elena Zamara, Stefano Milani, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|September 10, 2005
Thrombopoietin stimulates migration and activates multiple signaling pathways in hepatoblastoma cellsRoberto G Romanelli, Ilaria Petrai, Gaia Robino, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 26, 2016
Consensus conference on TIPS management: Techniques, indications, contraindicationsStefano Fagiuoli, Raffaele Bruno, Wilma Debernardi Venon, et al.
Pageof 8